About

Multiple myeloma is a cancer of plasma cells, a type of white blood cell, which can lead to bone pain, anemia, kidney problems, and frequent infections. Iberdomide is a cereblon E3 ligase modulator, a type of drug that directs the cell's own waste-disposal system to break down specific proteins that cancer cells need to survive. By degrading these key proteins, iberdomide may help stop the growth of myeloma cells in patients who have relapsed or no longer respond to other treatments.